 |
|
Is Teriparatide Superior in Treating Osteoporotic Vertebral Compression Fractures in Comparison to Bisphosphonates Treatment Alone: A 2-Year Retrospective Analysis
Vishnu Vikraman Nair, Vishal Kundnani, Abhijith Shetty, Manikant Anand, Mukul Jain, Nikhil Dewnany
Asian Spine J. 2023;17(6):1098-1107. Published online 2023 Dec 5 DOI: https://doi.org/10.31616/asj.2023.0109
|
|
Citations to this article as recorded by
 Comparison of osteoanabolic agents (teriparatide and romosozumab) with bisphosphonates in prevention of subsequent vertebral fractures in patients treated for osteoporotic vertebral fracture for 12 months: An observational cohort study
Keishi Maruo, Tomoyuki Kusukawa, Masakazu Toi, Tetsuto Yamaura, Masaru Hatano, Hayato Oishi, Kazuma Nagao, Fumihiro Arizumi, Kazuya Kishima, Norichika Yoshie, Toshiya Tachibana
Bone Reports.2024; 21: 101762. CrossRef The Effects of Longer Use of Teriparatide on Clinical and Radiographic Outcomes after Spinal Fusion in Geriatric Patients
Young-Hoon Kim, Kee-Yong Ha, Hyun W. Bae, Hyung-Youl Park, Young-Il Ko, Myung-Sup Ko, Sang-Il Kim
Medicina.2024; 60(6): 946. CrossRef Impact of Teriparatide and Denosumab on Clinical and Radiographic Outcomes in Osteoporotic Vertebral Compression Fractures
Byung-Taek Kwon, Dae-Woong Ham, Sang-Min Park, Ho-Joong Kim, Jin S. Yeom
Medicina.2024; 60(8): 1314. CrossRef Conservative Treatments in the Management of Acute Painful Vertebral Compression Fractures
Assil-Ramin Alimy, Athanasios D. Anastasilakis, John J. Carey, Stella D’Oronzo, Anda M. Naciu, Julien Paccou, Maria P. Yavropoulou, Willem F. Lems, Tim Rolvien
JAMA Network Open.2024; 7(9): e2432041. CrossRef
|